|
RYBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.798200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.560000E-03 |
| Normal-vs-Stage2 |
9.036800E-03 |
| Normal-vs-Stage3 |
1.063760E-03 |
| Normal-vs-Stage4 |
2.176100E-03 |
| Stage1-vs-Stage2 |
3.439000E-01 |
| Stage1-vs-Stage3 |
1.848240E-01 |
| Stage1-vs-Stage4 |
1.466360E-01 |
| Stage2-vs-Stage3 |
9.826600E-01 |
| Stage2-vs-Stage4 |
8.750400E-01 |
| Stage3-vs-Stage4 |
8.636400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.056300E-03 |
| Normal-vs-AfricanAmerican |
2.426600E-01 |
| Normal-vs-Asian |
2.535800E-02 |
| Caucasian-vs-AfricanAmerican |
4.870600E-01 |
| Caucasian-vs-Asian |
9.508400E-01 |
| AfricanAmerican-vs-Asian |
5.554000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.375150E-03 |
| Normal-vs-Female |
3.041100E-03 |
| Male-vs-Female |
1.495610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.383600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.740650E-03 |
| Normal-vs-Age(61-80Yrs) |
1.043770E-03 |
| Normal-vs-Age(81-100Yrs) |
2.561800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.928000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.402500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.417400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.824400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.690400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.266600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.714400E-02 |
| Classical-VS-Follicular |
2.825800E-04 |
| Classical-VS-Other |
6.220000E-01 |
| Classical-VS-Normal |
6.209600E-02 |
| Tall-VS-Follicular |
5.655200E-01 |
| Tall-VS-Other |
6.718600E-01 |
| Tall-VS-Normal |
3.295600E-03 |
| Follicular-VS-Other |
4.822600E-01 |
| Follicular-VS-Normal |
1.845360E-04 |
| Other-VS-Normal |
2.714200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.8617000000003E-05 |
| Normal-vs-N1 |
5.276300E-03 |
| N0-vs-N1 |
8.121600E-01 |
|
|
